삼성바이오로직스

It’s been another meaningful week at BIOPLUS-INTERPHEX KOREA 2025. Through engaging discussions and our dedicated presentation session, we exchanged insights on: ✓ Strategies to effectively shorten project timelines ✓ How standardized, data-driven operations enable consistent precision and seamless execution At Samsung Biologics, our goal remains the same: to keep every project on track and help life-saving therapies reach patients without delay. 🤝 Partner with Samsung Biologics for on-time project delivery. https://lnkd.in/g5FwenV Driven. For Life. Exellens™ Aspired. #Exellens #Partnership #CDMO #SamsungBiologics #OperationalExcellence #Biomanufacturing

We understand that your timelines are critical — our mission is to meet them with reliability and consistency. At Samsung Biologics, on-time project launch isn’t just a target; it’s a standard we uphold across every facility. Through ExellenS™, our optimized manufacturing framework, we embed our deep CMO expertise directly into the way we operate. By applying standardized and repeatable plant designs and unified processes across all sites, ExellenS™ minimizes variability, accelerates start-ups, and ensures a dependable flow for every project. This is how we deliver the reliability you need — so you can stay focused on bringing life-changing therapies to patients faster. 🔍 Learn more about the reliable standards built into ExellenS™: https://lnkd.in/eB_xAUJK #SamsungBiologics #CDMO #ExellenS #Reliability #OperationalExcellence #ManufacturingStandard

We’re counting down — just two weeks until CPHI Frankfurt 2025! Meet our team at 📍 Booth #5.1B66, where we’ll share how Samsung Biologics ensures every project stays on track, delivering on time, from development through to commercial delivery. Let’s connect and discover how we can empower your next breakthrough, together. 📅 Schedule your meeting today: https://lnkd.in/gSPNEngB #CPHI #CPHIFrankfurt #SamsungBiologics #CDMO #Networking

We’re live at BIOPLUS-INTERPHEX KOREA 2025 this week! 🚀 Join Samsung Biologics at COEX, Booth #K32, to learn how our integrated end-to-end CDMO services help bring therapies to patients faster. 🎤 Don’t miss our session this Thursday, October 16 at 12 PM (KST) in Conference Room #402, where Taeheui Lee, VP of Ab Cell Purification PD, will share insights on how we’re streamlining drug development to accelerate project timelines. Let’s connect and explore new ways to advance innovation together. #BioPlusInterphex #BIX2025 #SamsungBiologics #CDMO #Biopharma

Flexibility and integrated operations define CDMO excellence. Client satisfaction starts with a foundation of data-driven, strategic operations — where adaptable facilities and integrated processes ensure the consistent delivery of high-quality batches. 📜 Four of our experts — Soyeon Ahn, Daeryun Park, PE, Hyoseok Kim, and Joomyung Lee — share how CDMOs can enhance flexibility and resilience in both facility design and bioprocesses. Read more in International Biopharmaceutical Industry: https://lnkd.in/eZ_UzvQT #ClientSatisfaction #Flexibility #CDMO #SamsungBiologics #Biomanufacturing

When innovation converges with integrated end-to-end CDMOs, biopharmaceutical companies can optimize manufacturing performance. Digital twins amplify this impact by de-risking technology transfers, accelerating scale-up, and enabling right-first-time launches. Heejeong Kim, Vice President of Drug Substance Manufacturing at Samsung Biologics, shares her perspective on how bioprocess digital twins are becoming strategic engines shaping the future of biomanufacturing. 🔗 Read the full article: https://lnkd.in/gWnXipkR #SamsungBiologics #CDMO #DigitalTwin #Biomanufacturing #Innovation

It was a productive week at BioJapan 2025, engaging with peers and partners across the biopharmaceutical industry to explore how we can continue advancing global health together. 🙏 Thank you to everyone who visited our booth, joined our presentation sessions, and shared valuable insights with our team. Discussions like these continue to strengthen collaboration and drive innovation in biomanufacturing. We were also pleased to introduce ExellenS™, our optimized and standardized CMO framework designed to deliver unmatched plant equivalency, speed, and reliability across projects and sites. We look forward to building on these connections and exploring new opportunities ahead. 🔗https://lnkd.in/g5FwenV #SamsungBiologics #ExellenS #CDMO #Biomanufacturing #BioJapan2025 #Partnership

Introducing ExellenS™ ㅡ Samsung Biologics’ optimized manufacturing framework designed to embed equivalency and speed across every facility. Built on our four pillars of excellence in Client, Operations, Quality, and People, ExellenS™ applies Standardization, Simplification, and Scalability to ensure identical precision and reliability throughout our biomanufacturing network. For our clients, this means: ✔️ Faster tech transfers and rapid approvals ✔️ Predictable outcomes at every site ✔️ Unified digital platforms for smarter planning ExellenS™ reflects our deep commitment to providing partners with the flexibility, reliability, and confidence to succeed in an increasingly complex global market. 👉🏻 Learn more about ExellenS™: https://lnkd.in/gRmGHPaK #ExellenS #SamsungBiologics #CDMO #Biomanufacturing

🚀 Bio Japan 2025 kicks off today! Visit us at Booth D-105 to explore how we can advance biopharma manufacturing and build resilient supply chains together. 🎤 Don’t miss out on our seminars on Oct 8 (12:30–13:30), PACIFICO (F202): 1️⃣ Strategic Outsourcing for Supply Chain Resilience: Empowering CDMO Partnerships in a Complex World — James Choi, EVP & Head of Sales Support 2️⃣ Integrating Development and Manufacturing for Diverse Biologic Modalities — Kevin Sharp, EVP & Head of Sales & Operation 📅 Secure your spot and schedule a meeting here: https://lnkd.in/gpi3Pnah #BioJapan2025 #SamsungBiologics #CDMO #BiologicsManufacturing #Partnering

Join us today at 10 AM EDT for our webinar on how Samsung Organoids can advance your research and unlock new opportunities in the life sciences. Alexis Santana, Director of Organoid Sales at Samsung Biologics, will share insights on what’s driving innovation in organoids and how they help accelerate the early discovery and evaluation of new drug candidates. 📅 Register here: https://lnkd.in/gkvh7RDz #Organoids #LifeSciences #DrugDiscovery #CDMO #SamsungBiologics